LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?
- PMID: 19626831
LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?
Comment on
-
The role of LHRH antagonists in the treatment of prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):626-30. Oncology (Williston Park). 2009. PMID: 19626830 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical